![David Braun](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Braun
Nessuna posizione attualmente
Profilo
David Braun has held positions as an Independent Director at Cellect Biotechnology Ltd., Head of Operations and Research & Development at Newell Brands, Inc., and VP of Operations, Research & Development at Biosafe SA.
Precedenti posizioni note di David Braun
Società | Posizione | Fine |
---|---|---|
QUOIN PHARMACEUTICALS, LTD. | Direttore/Membro del Consiglio | - |
NEWELL BRANDS INC. | Corporate Officer/Principal | - |
Biosafe SA
![]() Biosafe SA Medical/Nursing ServicesHealth Services Biosafe SA operates as a medical technology company. It provides automated adult stem cell processing services. The firm specializes in the field of adult stem cell therapy, serving stem cell banks, hospitals and research institutes. The company was founded by Claude Fell and Lia Fell-Zakrajsek in 1997 and is headquartered in Eysins, Switzerland. | Direttore operativo | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
NEWELL BRANDS INC. | Producer Manufacturing |
Aziende private | 2 |
---|---|
Biosafe SA
![]() Biosafe SA Medical/Nursing ServicesHealth Services Biosafe SA operates as a medical technology company. It provides automated adult stem cell processing services. The firm specializes in the field of adult stem cell therapy, serving stem cell banks, hospitals and research institutes. The company was founded by Claude Fell and Lia Fell-Zakrajsek in 1997 and is headquartered in Eysins, Switzerland. | Health Services |
Cellect Biotechnology Ltd.
![]() Cellect Biotechnology Ltd. Medical SpecialtiesHealth Technology Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel. | Health Technology |
- Borsa valori
- Insiders
- David Braun